A detailed history of Trek Financial, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Trek Financial, LLC holds 735 shares of UTHR stock, worth $264,291. This represents 0.02% of its overall portfolio holdings.

Number of Shares
735
Previous 794 7.43%
Holding current value
$264,291
Previous $252,000 4.37%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $18,351 - $21,449
-59 Reduced 7.43%
735 $263,000
Q2 2024

Aug 12, 2024

BUY
$228.26 - $319.04 $181,238 - $253,317
794 New
794 $252,000
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $3.47 Million - $4.73 Million
16,856 New
16,856 $4.69 Million
Q2 2021

Aug 06, 2021

SELL
$170.47 - $211.93 $589,826 - $733,277
-3,460 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $532,632 - $604,981
3,460 New
3,460 $579,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Trek Financial, LLC Portfolio

Follow Trek Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trek Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trek Financial, LLC with notifications on news.